DLB
Dolby Laboratories, Inc.Price & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| video distribution program licensors | 40 | the quarter call | — |
| non-GAAP diluted EPS non-GAAP | $1.06 | first quarter of fiscal 2026 | — |
| non-GAAP net income non-GAAP | $103M | first quarter of fiscal 2026 | — |
| share repurchases | $70M | first quarter of fiscal 2026 | — |
| stock repurchase authorization available | $207M | first quarter of fiscal 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DLB
this stock
Dolby Laboratories, Inc.
|
$4.65B | -23.1% | +10.3% | 19.5 | 6.9% |
|
CTAS
Cintas Corp
|
$76.96B | +2.8% | +6.4% | 40.7 | 3.0% |
|
RELX
Relx PLC
|
$58.76B | -17.1% | — | — | 0.2% |
|
TRI
Thomson Reuters Corp /Can/
|
$42.43B | -25.3% | — | — | 3.4% |
|
CPRT
Copart Inc
|
$25.62B | -30.3% | +24.7% | 17.3 | 4.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DLB | -1.5% | -8.8% | -20.5% | -6.5% | -23.1% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -2.7% | -8.7% | -30.6% | -7.6% | -33.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.